pharma news

News

Introducing the Sunday Times Tech 100: Life sciences part 1

The 2026 Sunday Times Tech 100 list includes 23 companies in the life sciences arena, and in this article we focus on five in the software category.

News

Digital osteoarthritis, bulimia tools backed for NHS use

Guidance in the UK has cleared the way for NHS use of digital health technologies for people with osteoarthritis and eating disorder bulimia.

News

Sanofi plans amlitelimab dermatitis filing after new readout

Sanofi has said it will press ahead with regulatory filings for atopic dermatitis candidate amlitelimab, despite mixed data in phase 3.

News

Change of heart as NICE backs prostate cancer drug Talzenna

Thousands of men with prostate cancer will be offered a new treatment, Pfizer's Talzenna, after NICE made an about-turn on the drug.

News

Corxel's raises $287m for obesity drug, and other financings

Our latest biofinancing round-up sees big rounds for Corxel and Caldera, with Mendra, Think Bio, Exciva, Cytotheryx, and Infinitopes also raising cash

News

Ovarian cancer data restores faith in Corcept's relacorilant

After Corcept's setback with relacorilant in Cushing syndrome last month, the company has bounced back with strong survival data in ovarian cancer.

Introducing the Sunday Times Tech 100: Life sciences part 1

Digital osteoarthritis, bulimia tools backed for NHS use

Sanofi plans amlitelimab dermatitis filing after new readout

Change of heart as NICE backs prostate cancer drug Talzenna

Corxel's raises $287m for obesity drug, and other financings

Ovarian cancer data restores faith in Corcept's relacorilant

Lilly names Pennsylvania site for its latest US facility

How to meet your physicians where they are online

pharma news

Editor's Picks